Trends & Innovation: New Anti-Malaria Drug

Enzymes used by the malaria parasite to attack blood cells may be good targets for new anti-malaria drugs. A team lead by Pennsylvania University researchers has found the inhibiting the 2 parasite enzymes called peptidases, which consume hemoglobin in a host’s red blood cells, can starve the parasite to death.